JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB190653

Anti-SEBOV GP 抗体

Anti-SEBOV GP antibody

Be the first to review this product! Submit a review

|

(1 Publication)

Rabbit Polyclonal VGP antibody. Suitable for WB and reacts with Sudan ebolavirus, Recombinant full length protein - Zaire ebolavirus, Recombinant full length protein - Marburg virus, Recombinant full length protein - Sudan ebolavirus samples. Cited in 1 publication. Immunogen corresponding to Native Full Length Protein corresponding to Sudan ebolavirus - Uganda (2000) GP.

別名を表示する

Envelope glycoprotein, GP

1 Images
Western blot - Anti-SEBOV GP antibody (AB190653)
  • WB

Supplier Data

Western blot - Anti-SEBOV GP antibody (AB190653)

The blot was visualized using an anti rabbit HRP conjugate and chromogenic substrate.

GP is visualized as multiple bands representig different glycosylation patterns and GP subunits.

All lanes:

Western blot - Anti-SEBOV GP antibody (ab190653) at 5 µg/mL

Lane 1:

SEBOV VLP at 4 µg

Lane 2:

ZEBOV VLP at 4 µg

Lane 3:

MARV VLP at 4 µg

Lane 4:

rSEBOV GP-HA tag expressed in mammalian cells at 0.2 µg

true

Key facts

宿主種

Rabbit

クローン性

Polyclonal

アイソタイプ

IgG

キャリアフリー

No

交差種

Zaire ebolavirus, Marburg virus, Sudan ebolavirus

アプリケーション

WB

applications

免疫原

Native Full Length Protein corresponding to Sudan ebolavirus - Uganda (2000) GP.

Q7T9D9

特異性

ab190653 detects recombinant SEBOV GP (modified) and GP expressed in virus-like particles (VLP). It cross reacts to Zaire Ebola Virus (ZEBOV) GP expressed in VLP. A very slight cross-reactivity to Marburg virus (MARV) may also be observed. Cross reactivity to the HA epitope tag of the immunogen may also be observed.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Marburg virus": { "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "" }, "Recombinant full length protein - Marburg virus": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1 - 1/5", "WB-species-notes": "<p></p>" }, "Recombinant full length protein - Sudan ebolavirus": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1 - 1/5", "WB-species-notes": "<p></p>" }, "Recombinant full length protein - Zaire ebolavirus": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1-5 µg/mL", "WB-species-notes": "<p></p>" }, "Sudan ebolavirus": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1-5 µg/mL", "WB-species-notes": "<p></p>" }, "Zaire ebolavirus": { "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "" } } }

出荷温度及び保存条件

製品の状態
Liquid
精製方法
Affinity purification Protein A
バッファー組成
Preservative: 0.01% Sodium azide Constituents: PBS
出荷温度
Blue Ice
短期保存期間
1-2 weeks
短期保存温度
+4°C
長期保存温度
-20°C
分注に関する情報
Upon delivery aliquot
保管に関する情報
Avoid freeze / thaw cycle

補足情報

This supplementary information is collated from multiple sources and compiled automatically.

SEBOV GP also known as Sudan ebolavirus glycoprotein functions mechanically as a structural protein on the virus surface facilitating entry into host cells. This glycoprotein weighs approximately 64 kDa and is expressed on the virion envelope. It mediates attachment to host cells by binding to cellular receptors initiating the endocytosis process necessary for viral infection. SEBOV GP’s trimeric structure plays an important role during membrane fusion after the virus is taken into the host cell's endosome.
Biological function summary

SEBOV GP enables the Sudan strain of the ebolavirus to evade the host's immune response. The protein is part of a larger complex formed with other viral proteins such as VP40 and VP30 which aids in assembling and budding new viral particles from infected cells. SEBOV GP has a significant influence on pathogenesis by affecting cytokine production and causing cytopathic effects which contribute to the viral disease symptoms.

Pathways

SEBOV GP is involved in the viral infection pathway and membrane trafficking. It interacts with host proteins such as NPC1 during the fusion process after internalization. SEBOV GP indirectly associates with the interferon response pathway by modulating host immune signaling contributing to its immune evasion strategies. Through its actions this glycoprotein impacts various transcription pathways related to immune system regulation.

SEBOV GP relates directly to viral hemorrhagic fevers caused by the Sudan ebolavirus. It also influences severe components of the immune response leading to multi-organ dysfunction syndrome. The glycoprotein has connections with human proteins like TIM-1 which serves as an entry co-factor important in pathogenesis. Targeting SEBOV GP with antibodies or antivirals could provide therapeutic strategies for Ebola virus disease aiming to block virus entry and replication.

製品プロトコール

For this product, it's our understanding that no specific protocols are required. You can visit:

ターゲットの情報

Envelope glycoprotein. Trimeric GP1,2 complexes form the virion surface spikes and mediate the viral entry processes, with GP1 acting as the receptor-binding subunit and GP2 as the membrane fusion subunit. At later times of infection, down-regulates the expression of various host cell surface molecules that are essential for immune surveillance and cell adhesion. Down-modulates several integrins including ITGA1, ITGA2, ITGA3, ITGA4, ITGA5, ITGA6, ITGAV and ITGB1. This decrease in cell adhesion molecules may lead to cell detachment, contributing to the disruption of blood vessel integrity and hemorrhages developed during infection (cytotoxicity). Interacts with host TLR4 and thereby stimulates the differentiation and activation of monocytes leading to bystander death of T-lymphocytes. Down-regulates as well the function of host natural killer cells. Counteracts the antiviral effect of host BST2/tetherin that restricts release of progeny virions from infected cells. However, cooperates with VP40 and host BST2 to activate canonical NF-kappa-B pathway in a manner dependent on neddylation.. Shed GP. Functions as a decoy for anti-GP1,2 antibodies thereby contributing to viral immune evasion. Interacts and activates host macrophages and dendritic cells inducing up-regulation of cytokine transcription. This effect is mediated throught activation of host TLR4.. GP1. Responsible for binding to the receptor(s) on target cells. Interacts with CD209/DC-SIGN and CLEC4M/DC-SIGNR which act as cofactors for virus entry into dendritic cells (DCs) and endothelial cells (By similarity). Binding to the macrophage specific lectin CLEC10A also seems to enhance virus infectivity (By similarity). Interaction with FOLR1/folate receptor alpha may be a cofactor for virus entry in some cell types, although results are contradictory (By similarity). Members of the Tyro3 receptor tyrosine kinase family also seem to be cell entry factors in filovirus infection (By similarity). Once attached, the virions are internalized through clathrin-dependent endocytosis and/or macropinocytosis. After internalization of the virus into the endosomes of the host cell, proteolysis of GP1 by two cysteine proteases, CTSB/cathepsin B and CTSL/cathepsin L removes the glycan cap and allows GP1 binding to the host entry receptor NPC1. NPC1-binding, Ca(2+) and acidic pH induce a conformational change of GP2, which unmasks its fusion peptide and permit membranes fusion (By similarity).. GP2. Acts as a class I viral fusion protein. Under the current model, the protein has at least 3 conformational states : pre-fusion native state, pre-hairpin intermediate state, and post-fusion hairpin state. During viral and target cell membrane fusion, the coiled coil regions (heptad repeats) assume a trimer-of-hairpins structure, positioning the fusion peptide in close proximity to the C-terminal region of the ectodomain. The formation of this structure appears to drive apposition and subsequent fusion of viral and target cell membranes. Responsible for penetration of the virus into the cell cytoplasm by mediating the fusion of the membrane of the endocytosed virus particle with the endosomal membrane. Low pH in endosomes induces an irreversible conformational change in GP2, releasing the fusion hydrophobic peptide.
See full target information GP

文献 (1)

Recent publications for all applications. Explore the full list and refine your search

PloS one 18:e0289745 PubMed37556495

2023

Analytical sameness methodology for the evaluation of structural, physicochemical, and biological characteristics of Armlupeg: A pegfilgrastim biosimilar case study.

Applications

Unspecified application

Species

Unspecified reactive species

Arati Deshmukh,Rishank Goyal,Kalyana Sundaram,Kaustubh Dange,Tejshri Lakhote,Sanjay Niranjan,Jennifer Bharucha,Ashok Mishra,Bhavesh Vats,Sanjay Tiwari
View all publications

Abcam product promise

当社は、高品質な試薬を通じてお客様の研究を力強くサポートすることをお約束いたします。ご使用いただく各段階で、常にお客様をサポートできる体制を整えております。万が一、製品が期待通りに機能しない場合は、「Abcam Product Promise」による当社保証制度に基づき、安心してご利用いただけます。
保証に関する詳細については利用規約をご確認ください。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com